NCT02172534View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Conditions
Cystic Fibrosis
Interventions
DRUG

Tiotropium bromide low

DRUG

Tiotropium bromide medium

DRUG

Tiotropium bromide high

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172534 - Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients | Biotech Hunter | Biotech Hunter